Nobody Talks to Pregnant Women About Their Eyes - And Why They Should
From fertility treatment to delivery, your eyes change in ways that matter. Your ObGyn probably never mentioned it.
Here is everything you need to know, including when to see an eye doctor and how to handle eye makeup when your eyes are at their most sensitive.
The Conversation Nobody Is Having
Think about everything your ObGyn discusses during prenatal care. Weight. Blood pressure. Glucose screening. Genetic testing. Exercise. Diet. Sleep position. Dental visits.
Now think about your eyes.
Nothing.
Your ObGyn almost certainly said nothing about your eyes.
This is a remarkable gap. Pregnancy produces real, measurable changes in your eyes. So do the fertility medications that many women take to get pregnant in the first place. Vision can fluctuate. Eyes dry out. Contact lenses stop fitting. And in rare cases, visual symptoms can be the first sign of a serious complication like preeclampsia.
Yet no one brings it up. Not at the first prenatal visit. Not at any prenatal visit. The topic does not appear on standard prenatal counseling checklists. Most ObGyn residency training covers ocular emergencies (scotomas in preeclampsia, for example) but says almost nothing about the routine eye changes that affect millions of pregnant women every year.
The result is predictable. Women notice their vision is different. They wonder if something is wrong. They Google at 2 a.m. They either worry unnecessarily about something benign, or they ignore a symptom that actually needed attention.
A woman’s focus during pregnancy (so to speak) is somewhere else entirely. That is understandable. But it does not mean her eyes should be forgotten.
It Starts Before Pregnancy: Fertility Medications and Your Eyes
For women undergoing fertility treatment, eye changes can begin before pregnancy even starts.
Clomiphene citrate (Clomid), the most commonly prescribed fertility medication, has well-documented visual side effects. These include blurred vision, flashing lights, shimmering in the visual field, light sensitivity, and a phenomenon called palinopsia, where afterimages linger longer than normal (4, 5). These effects occur because clomiphene is an estrogen receptor blocker, and estrogen receptors exist in the retina and visual pathways, not just the reproductive system.
Most visual symptoms from clomiphene are mild and resolve when the medication is stopped. But not always. Case reports document patients with visual disturbances persisting years after discontinuing the drug (5). Rare but serious complications include central retinal vein occlusion and optic neuropathy (4, 6).
The prescribing information for clomiphene states clearly that the drug should be discontinued if visual symptoms occur. Yet how many women starting Clomid are told to watch for visual changes? How many know that blurred vision on day three of their Clomid cycle is a recognized side effect and not just fatigue?
Gonadotropin therapy (injectable FSH, used in IVF cycles) has also been associated with ocular changes. IVF treatment increases vascular endothelial growth factor (VEGF) levels, and elevated VEGF has been linked in case reports to retinal complications including retinal detachment and choroidal neovascularization (4). These are rare events, but they underscore the point: fertility treatment affects the eyes, and patients deserve to know that before they start.
The bottom line for women trying to conceive: If you are taking clomiphene or undergoing IVF and you notice any visual changes, blurred vision, flashing lights, shimmering, spots, or lingering afterimages, tell your fertility doctor immediately. Do not assume it is stress or fatigue. It may be a medication effect that requires evaluation.
What you are about to read will change how you walk into your next exam room.
